Oncology & Cancer

An epigenetic marker can predict survival in childhood leukaemia

A molecular epigenetic marker is important for distinguishing patients with childhood leukaemia at high and low risk of relapse even at the time of diagnosis. It can be important to adapt early on as to what treatment to ...

Oncology & Cancer

Scientists map the genetic evolution of childhood leukaemia

The key genetic events responsible for initiating the early stages of a type of childhood leukaemia have been identified by scientists at The Institute of Cancer Research, London. Insights into the 'founder' genetic mutation ...

page 1 from 4